Skip to content

Lower radiation exposure did not establish preserved sexual function after prostate treatment

Radiation doses to several nearby structures were lower after spacer insertion in a retrospective prostate cancer cohort, while sexual function declined during later follow-up.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Spacer insertion was associated with lower radiation doses to some structures involved in erectile function. Sexual function scores nevertheless declined during later follow-up. These findings do not establish preservation of sexual function or show what would have happened without spacers, because the abstract describes no comparison group that did not receive them.

Keep in mind

This summary uses only the abstract. The retrospective study describes no comparison cohort without spacers, so it cannot establish whether spacers changed the course of sexual function.

THE NUMBERS, WITH CONTEXT

What researchers found

1.66 Gy

Mean reduction in left neurovascular bundle radiation dose

After versus before spacer insertion; 95% CI 1.32–2.00 Gy. This measures radiation exposure rather than a sexual-function effect.

Cancers (Basel), 2026 · Original source ↓

Radiation dose findings

Statistically significant dose reductions were reported for the right neurovascular bundle and right perineal artery. Changes in dose to the penile bulb and left perineal artery did not reach statistical significance.

Sexual function over time

Sexual function was tracked with EPIC scores and declined significantly during later follow-up. That outcome addresses a different question from radiation exposure: whether sexual function was maintained after treatment.

CHECK THE ORIGINAL

The original publication

Impact of Hydrogel Spacer Insertion on Radiation Dose to Erectile Structures and Longitudinal Sexual Function in Prostate Cancer Patients.

Zeru E, Feng Z, Dong L et al.
Cancers (Basel) · 2026

PubMed ID
41827747
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.